Breakthrough may change treatment for metastatic prostate cancer
August 07, 2026
August 07, 2026
ITHACA, New York, Aug. 7 -- Cornell University posted the following news:
* * *
Breakthrough may change treatment for metastatic prostate cancer
*
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center (MSK) and investigators at sever . . .
* * *
Breakthrough may change treatment for metastatic prostate cancer
*
Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a phase 3 clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center (MSK) and investigators at sever . . .